Cargando…
Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA
BACKGROUND: Spinal Muscular Atrophy (SMA) is the leading genetic cause of infantile death. It is caused by the loss of functional Survival Motor Neuron 1 (SMN1). There is a nearly identical copy gene, SMN2, but it is unable to rescue from disease due to an alternative splicing event that excises a n...
Autores principales: | Mattis, Virginia B, Fosso, Marina Y, Chang, Cheng-Wei, Lorson, Christian L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789732/ https://www.ncbi.nlm.nih.gov/pubmed/19948047 http://dx.doi.org/10.1186/1471-2202-10-142 |
Ejemplares similares
-
Functional characterization of SMN evolution in mouse models of SMA
por: Osman, Erkan Y., et al.
Publicado: (2019) -
DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration
por: Aslesh, Tejal, et al.
Publicado: (2023) -
Optimization of trans-Splicing for Huntington's Disease RNA Therapy
por: Rindt, Hansjörg, et al.
Publicado: (2017) -
Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model
por: Januel, Camille, et al.
Publicado: (2022) -
PROJECT ADMINISTRATION AGREEMENT K1496-TT-AB-007P-MedAustron
por: The European Organization for Nuclear Reserch, Cern, et al.
Publicado: (2008)